In CKD it is likely that PlGF/Flt-1 signaling partly contributes to phenotypic changes of CKD such as ventricular hypertrophy and cardiac fibrosis with accumulation of macrophages and T cells in the heart, and smooth muscle cell proliferation and plaque formation in large arteries [61,62]. This evidence concerns the gene FLT1 and chronic kidney disease.